Welsh WJ - Search Results

1

Highly potent triazole-based tubulin polymerization inhibitors.

Zhang Q, Peng Y, Wang XI, Keenan SM, Arora S, Welsh WJ. Zhang Q, et al. Among authors: welsh wj. J Med Chem. 2007 Feb 22;50(4):749-54. doi: 10.1021/jm061142s. Epub 2007 Jan 24. J Med Chem. 2007. PMID: 17249649 Free PMC article.

2

Quantitative structure-activity relationships (QSARs) for estrogen binding to the estrogen receptor: predictions across species.

Tong W, Perkins R, Strelitz R, Collantes ER, Keenan S, Welsh WJ, Branham WS, Sheehan DM. Tong W, et al. Among authors: welsh wj. Environ Health Perspect. 1997 Oct;105(10):1116-24. doi: 10.1289/ehp.971051116. Environ Health Perspect. 1997. PMID: 9353176 Free PMC article.

3

Three-dimensional quantitative structure-activity relationship (3D-QSAR) models for a novel class of piperazine-based stromelysin-1 (MMP-3) inhibitors: applying a "divide and conquer" strategy.

Ambrose Amin E, Welsh WJ. Ambrose Amin E, et al. Among authors: welsh wj. J Med Chem. 2001 Nov 8;44(23):3849-55. doi: 10.1021/jm010236t. J Med Chem. 2001. PMID: 11689071

4

Influence of the structural diversity of data sets on the statistical quality of three-dimensional quantitative structure-activity relationship (3D-QSAR) models: predicting the estrogenic activity of xenoestrogens.

Yu SJ, Keenan SM, Tong W, Welsh WJ. Yu SJ, et al. Among authors: welsh wj. Chem Res Toxicol. 2002 Oct;15(10):1229-34. doi: 10.1021/tx0255875. Chem Res Toxicol. 2002. PMID: 12387618

5

Three-dimensional structure-activity relationship modeling of cocaine binding to two monoclonal antibodies by comparative molecular field analysis.

Paula S, Tabet MR, Keenan SM, Welsh WJ, Ball WJ Jr. Paula S, et al. Among authors: welsh wj. J Mol Biol. 2003 Jan 17;325(3):515-30. doi: 10.1016/s0022-2836(02)01235-4. J Mol Biol. 2003. PMID: 12498800

6

Three-dimensional structure-activity relationship modeling of digoxin inhibition and docking to Na+,K+-ATPase.

Ball WJ Jr, Farr CD, Paula S, Keenan SM, Delisle RK, Welsh WJ. Ball WJ Jr, et al. Among authors: welsh wj. Ann N Y Acad Sci. 2003 Apr;986:296-7. doi: 10.1111/j.1749-6632.2003.tb07191.x. Ann N Y Acad Sci. 2003. PMID: 12763827 No abstract available.

7

Characteristics of the Plasmodium falciparum PK5 ATP-binding site: implications for the design of novel antimalarial agents.

Keenan SM, Welsh WJ. Keenan SM, et al. Among authors: welsh wj. J Mol Graph Model. 2004 Jan;22(3):241-7. doi: 10.1016/j.jmgm.2003.09.002. J Mol Graph Model. 2004. PMID: 14629982

8

Rational inhibitor design and iterative screening in the identification of selective plasmodial cyclin dependent kinase inhibitors.

Keenan SM, Geyer JA, Welsh WJ, Prigge ST, Waters NC. Keenan SM, et al. Among authors: welsh wj. Comb Chem High Throughput Screen. 2005 Feb;8(1):27-38. doi: 10.2174/1386207053328183. Comb Chem High Throughput Screen. 2005. PMID: 15720195 Review.

9

3D-QSAR comparative molecular field analysis on opioid receptor antagonists: pooling data from different studies.

Peng Y, Keenan SM, Zhang Q, Kholodovych V, Welsh WJ. Peng Y, et al. Among authors: welsh wj. J Med Chem. 2005 Mar 10;48(5):1620-9. doi: 10.1021/jm049117e. J Med Chem. 2005. PMID: 15743203

10

Benzotropolone inhibitors of estradiol methylation: kinetics and in silico modeling studies.

Lambert JD, Chen D, Wang CY, Ai N, Sang S, Ho CT, Welsh WJ, Yang CS. Lambert JD, et al. Among authors: welsh wj. Bioorg Med Chem. 2005 Apr 1;13(7):2501-7. doi: 10.1016/j.bmc.2005.01.037. Bioorg Med Chem. 2005. PMID: 15755652

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

155 results

Search Page

Filters